APA (7th ed.) Citation

RJ, Z., W, W., Y, M., XM, S., S, W., & ZH, Z. (2026). [The Clinical Value of Plasma cfTFEB and miR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma]. Zhongguo shi yan xue ye xue za zhi, 34(1), 99. https://doi.org/10.19746/j.cnki.issn.1009-2137.2026.01.014

Chicago Style (17th ed.) Citation

RJ, Zhang, Wang W, Meng Y, Shi XM, Wang S, and Zhang ZH. "[The Clinical Value of Plasma CfTFEB and MiR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma]." Zhongguo Shi Yan Xue Ye Xue Za Zhi 34, no. 1 (2026): 99. https://doi.org/10.19746/j.cnki.issn.1009-2137.2026.01.014.

MLA (9th ed.) Citation

RJ, Zhang, et al. "[The Clinical Value of Plasma CfTFEB and MiR-1246 in Predicting the Efficacy of Bortezomib Treatment for Patients with Multiple Myeloma]." Zhongguo Shi Yan Xue Ye Xue Za Zhi, vol. 34, no. 1, 2026, p. 99, https://doi.org/10.19746/j.cnki.issn.1009-2137.2026.01.014.